UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Digital Pathology

Digital Pathology Goes Mobile

Medical Applications on Smartphones

Mobile technology could act as a radical stimulus in aiding digital pathology on to a totally new level in remitting and delivering clinical diagnostics.

Read More

Tele-Consultation Systems for Today’s Pathologists

Pathology is dealing with an area of diagnostics that is extremely variable. General pathologists are able to diagnose virtually any disease, but in rare or complex cases it is common practice to consult an expert.

Read More

Artificial Intelligence – Influencing The Clinical Practice Of Pathologists

Artificial intelligence based applications are quickly improving and they are expected to be a game changer in many fields, including transportation and medicine.

Read More

The Best of Digital Pathology in 2017

It is that time of the year to celebrate the most significant breakthroughs and accomplishments in the field of digital pathology. 2017 has been an exciting year with Philips receiving FDA approval to market their IntelliSite Pathology Solution for primary diagnostic use in the US. 

Read More

From Validation to Practice: Transforming Pathology with Aperio Solutions

Pathology Departments today are faced with many challenges in regards to effectively handling their workflow. More pathologists and technologists are retiring, while demand for specialist pathologists is increasing. Hospital laboratories are being forced to consolidate services and are seeking tools that can help them effectively provide more services without impacting on patient treatment.

Read More

Open Digital Pathology – Principles and Limitations

Open science paradigm promotes open, reproducible science through the sharing of all research processes, data, material and methods. Here, Raphaël Marée from Cytomine Scientific, discusses his thoughts on open digital pathology.

Read More

How Beneficial is Digital Pathology for the Laboratory Administrator?

Whether in a research or clinical lab, digital pathology holds a great deal of promise for all stakeholders. Earlier this year, a digital pathology platform obtained FDA clearance for whole slide imaging, thereby increasing both awareness and applicability of digital pathology. It may, however, be difficult for hospitals and laboratories to justify the acquisition costs of digital pathology platforms if one only looks on the surface. Matt Houliston from Definiens looks at the workflow and economic benefits of adopting digital pathology beyond the perhaps more obvious clinical benefits.

Read More

Quantitative Image Analysis Guidelines: An Open letter from Liron Pantanowitz

Dear Colleagues,

There has been a steady increase in the adoption of Quantitative Image Analysis (QIA) for diagnostic purposes, especially for breast biomarker testing.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive